Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan F Barker

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Thorax|September 24, 2014
Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trialDiana Bilton, Gregory Tino, Alan F Barker, et al.
American Journal of Respiratory Cell and Molecular Biology|August 11, 2007
IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiencyDawn L Demeo, Edward J Campbell, Alan F Barker, et al.
American Journal of Respiratory and Critical Care Medicine|November 10, 2009
An official American thoracic society statement: position statement on ATS activities for the promotion of respiratory and sleep/wake health and the care of the critically ill in the United StatesLee K Brown, Derek C Angus, Matthew G Marin, et al.
Epigenetics|May 24, 2012
Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiencyMateusz Siedlinski, Barbara Klanderman, Robert A Sandhaus, et al.
Thorax|March 29, 2007
Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiencyDawn L Demeo, Robert A Sandhaus, Alan F Barker, et al.
Chest|March 15, 2014
A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasisAlexandra L Quittner, Kristen K Marciel, Matthias A Salathe, et al.
Respiratory Research|February 24, 2012
Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiencyWoo Jin Kim, Alice M Wood, Alan F Barker, et al.
The Lancet. Respiratory Medicine|August 26, 2014
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trialsAlan F Barker, Anne E O'Donnell, Patrick Flume, et al.
The European Respiratory Journal|July 11, 2015
Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseasesNishant Gupta, Riffat Meraj, Daniel Tanase, et al.
The European Respiratory Journal|March 8, 2014
Circulating polymers in α1-antitrypsin deficiencyLu Tan, Jennifer A Dickens, Dawn L Demeo, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Thorax|September 24, 2014
Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trialDiana Bilton, Gregory Tino, Alan F Barker, et al.
American Journal of Respiratory Cell and Molecular Biology|August 11, 2007
IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiencyDawn L Demeo, Edward J Campbell, Alan F Barker, et al.
American Journal of Respiratory and Critical Care Medicine|November 10, 2009
An official American thoracic society statement: position statement on ATS activities for the promotion of respiratory and sleep/wake health and the care of the critically ill in the United StatesLee K Brown, Derek C Angus, Matthew G Marin, et al.
Epigenetics|May 24, 2012
Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiencyMateusz Siedlinski, Barbara Klanderman, Robert A Sandhaus, et al.
Thorax|March 29, 2007
Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiencyDawn L Demeo, Robert A Sandhaus, Alan F Barker, et al.
Chest|March 15, 2014
A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasisAlexandra L Quittner, Kristen K Marciel, Matthias A Salathe, et al.
Respiratory Research|February 24, 2012
Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiencyWoo Jin Kim, Alice M Wood, Alan F Barker, et al.
The Lancet. Respiratory Medicine|August 26, 2014
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trialsAlan F Barker, Anne E O'Donnell, Patrick Flume, et al.
The European Respiratory Journal|July 11, 2015
Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseasesNishant Gupta, Riffat Meraj, Daniel Tanase, et al.
The European Respiratory Journal|March 8, 2014
Circulating polymers in α1-antitrypsin deficiencyLu Tan, Jennifer A Dickens, Dawn L Demeo, et al.
Pageof 4